Chemical Analysis of Amyloid β Protein in CAA

作者: Alex E. Roher , Yu-Min Kuo , Alexander A. Roher , Mark R. Emmerling , Warren J. Goux

DOI: 10.1007/978-94-017-1007-7_9

关键词:

摘要: Substantial evidence demonstrates that amyloid deposition in the cerebral vasculature plays a major role pathophysiology of Alzheimer’s disease. Chemical and immunohistochemical analyses have demonstrated Aβ40 Aβ42 peptides are present vascular deposits with preponderance former peptide. The accumulation cerebrovascular leads to obliteration capillary lumen destruction arterial myocytes resulting hypoperfusion loss control blood flow. Post-translational modifications such as racemization, isomerization, cyclization, oxidation N-terminal degradation largely contribute insolubility proteolytic resistance exhibited by Aβ filaments. strong association other proteins, carbohydrates lipids results additional stability. There appears be positive correlation between magnitude dosage apolipoprotein E4.

参考文章(66)
A Asami-Odaka, T Iwatsubo, N Suzuki, H Shimada, H Fukumoto, Y Ihara, Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques. American Journal of Pathology. ,vol. 148, pp. 259- 265 ,(1996)
R. Okeda, H. Funato, M. Yoshimura, Y. Ihara, K. Ishikawa, K. Namekata, K. Kusui, N. Ohkoshi, A. Tamaoka, Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. American Journal of Pathology. ,vol. 152, pp. 1633- 1640 ,(1998)
R. O. Weller, C. B. E. Inman, E. T. Zhang, Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. Journal of Anatomy. ,vol. 170, pp. 111- 123 ,(1990)
G Evin, Q X Li, S Whyte, J E Tanner, K Beyreuther, C L Masters, Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets. Laboratory Investigation. ,vol. 78, pp. 461- 469 ,(1998)
C. Nordstedt, J. Näslund, J. Thyberg, E. Messamore, S.E. Gandy, L. Terenius, Human neutrophil phagocytic granules contain a truncated soluble form of the Alzheimer beta/A4 amyloid precursor protein (APP). Journal of Biological Chemistry. ,vol. 269, pp. 9805- 9810 ,(1994) , 10.1016/S0021-9258(17)36954-5
P. Hedera, R. P. Friedland, D. R. D. Premkumar, R. N. Kalaria, D. L. Cohen, Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. American Journal of Pathology. ,vol. 148, pp. 2083- 2095 ,(1996)
Roy O. Weller, Adrian Massey, Tracey A. Newman, Margaret Hutchings, Yu-Min Kuo, Alex E. Roher, Cerebral Amyloid Angiopathy The American Journal of Pathology. ,vol. 153, pp. 725- 733 ,(1998) , 10.1016/S0002-9440(10)65616-7
H Mori, K Takio, M Ogawara, D.J. Selkoe, Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. Journal of Biological Chemistry. ,vol. 267, pp. 17082- 17086 ,(1992) , 10.1016/S0021-9258(18)41896-0
N. J. Cairns, M. N. Rossor, L. Lannfelt, T. Iwatsubo, P. L. Lantos, B. Winblad, N. Bogdanovic, Y. Ihara, D. M. A. Mann, M. L. C. Maat-Schieman, Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. American Journal of Pathology. ,vol. 148, pp. 1257- 1266 ,(1996)